SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nektar Therapeutics (CA) Release: Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the American Society of Clinical Oncology 2011 Breast Cancer Symposium